Debio 1453
Alternative Names: Debio-1453Latest Information Update: 06 Jun 2025
At a glance
- Originator Debiopharm; Nobelex Biotech
- Class Antibacterials; Small molecules
- Mechanism of Action Enoyl ACP reductase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Gonorrhoea